Hydrochloric Acid → N-(4-(((3S,5S)-3,5-Dimethylmorpholino)methyl)-2,5-difluorophenyl)-5-fluoro-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amine hydrochloride
반응식
[CH3:1][C@@H:2]1[N:7]([CH2:8][C:9]2[C:14]([F:15])=[CH:13][C:12]([NH:16][C:17]3[N:22]=[C:21]([C:23]4[N:27]([CH:28]5[CH2:33][CH2:32][O:31][CH2:30][CH2:29]5)[C:26]([CH3:34])=[N:25][CH:24]=4)[C:20]([F:35])=[CH:19][N:18]=3)=[C:11]([F:36])[CH:10]=2)[C@@H:6]([CH3:37])[CH2:5][O:4][CH2:3]1.[ClH:38]>ClCCl>[ClH:38].[CH3:1][C@@H:2]1[N:7]([CH2:8][C:9]2[C:14]([F:15])=[CH:13][C:12]([NH:16][C:17]3[N:22]=[C:21]([C:23]4[N:27]([CH:28]5[CH2:33][CH2:32][O:31][CH2:30][CH2:29]5)[C:26]([CH3:34])=[N:25][CH:24]=4)[C:20]([F:35])=[CH:19][N:18]=3)=[C:11]([F:36])[CH:10]=2)[C@@H:6]([CH3:37])[CH2:5][O:4][CH2:3]1참가 물질
4
반응물 2
생성물 1
시약·촉매·용매 1
실험 절차
N-(4-(((3S,5S)-3,5-dimethylmorpholino)methyl)-2,5-difluorophenyl)-5-fluoro-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amine (16 mg) was dissolved in dichloromethane (4 ml) and HCl (1M in diethyl ether, 0.05 ml) was added. The solvents were evaporated to give the title compound (0.015 g) as a solid.
후처리
- customThe solvents were evaporated
출처 및 근거
- ORD 기록
- ord-41addefe23d442708ddf864b4c61529d
- 출처 데이터셋
- uspto-grants-2012_05
- 특허 번호
- US08178529B2
반응 노트
불러오는 중…